GlaxoSmithKline On The Defensive
Diabetes Drug, Avandia Is Cited For Potential Risk Of Heart Disease. FDA Panel Suggest Removing Avandia From The Market. Avandia was the topic of discussion. A new drug available from big pharma prescription drug producers. A panel of federal advisors recently discussed whether Avandia sales should be limited.
Keywords: Avandia, diabetes, diabetes drug, Drug, FDA, glaxo, glaxosmithkline, heart disease, lab, prescription, risk